Skip to main content

Table 3 Tumor response after treatment

From: Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma

Response DP group
n = 103
S-1 group
n = 72
p value
CR 29 (28.2%) 18 (25.0%)  
PR 47 (45.6%) 31 (43.1%)  
SD 25 (24.3%) 21 (29.1%)  
PD 2 (1.9%) 2 (2.8%)  
ORR 76 (73.8%) 49 (68.1%) 0.497
  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, ORR objective response rate